Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

One-Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry

(2014) Andrea Rubboli et al.   CLINICAL CARDIOLOGY

Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey

(2014) T. S. Potpara et al.   EUROPACE

Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review

(2014) DA Lane et al.   HEALTH TECHNOLOGY ASSESSMENT

A prospective validation of the SAME-TT2R2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin

(2014) Daniela Poli et al.   Internal and Emergency Medicine

Feasibility and Safety of Uninterrupted Rivaroxaban for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

(2014) Dhanunjaya Lakkireddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel

(2014) Raffaele de Caterina et al.   THROMBOSIS AND HAEMOSTASIS

New‐Onset Atrial Fibrillation is Associated With Cardiovascular Events Leading to Death in a First Time Myocardial Infarction Population of 89 703 Patients With Long‐Term Follow‐Up: A Nationwide Study

(2014) Casper N. Bang et al.   Journal of the American Heart Association

Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: Design of the MUSICA-2 randomized trial

(2013) Antonia Sambola et al.   AMERICAN HEART JOURNAL

Thrombocytopenia, Dual Antiplatelet Therapy, and Heparin Bridging Strategy Increase Pocket Hematoma Complications in Patients Undergoing Cardiac Rhythm Device Implantation

(2013) Huang-Chung Chen et al.   CANADIAN JOURNAL OF CARDIOLOGY

The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation

(2013) Axel Schlitt et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin

(2013) Stavros Apostolakis et al.   CHEST

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study

(2013) Stuart J. Connolly et al.   CIRCULATION

Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature

(2013) Stefan H. Hohnloser et al.   EUROPACE

Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey

(2013) G. Y. H. Lip et al.   EUROPACE

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

(2013) Hein Heidbuchel et al.   EUROPACE

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF)

(2013) Paulus Kirchhof et al.   EUROPACE

Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis

(2013) Aref A. Bin Abdulhak et al.   EUROPACE

A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

(2013) Gregory Y.H. Lip et al.   EUROPACE

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

(2013) P. Kirchhof et al.   EUROPACE

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

(2013) J. H. Alexander et al.   EUROPEAN HEART JOURNAL

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial

(2013) Kenneth W. Mahaffey et al.   EUROPEAN HEART JOURNAL

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060

(2013) B. P. Krijthe et al.   EUROPEAN HEART JOURNAL

New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis

(2013) J. Oldgren et al.   EUROPEAN HEART JOURNAL

Risk of Major Adverse Cardiac Events Following Noncardiac Surgery in Patients With Coronary Stents

(2013) Mary T. Hawn et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation

(2013) Torben Bjerregaard Larsen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Triple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral Anticoagulation

(2013) Nikolaus Sarafoff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention

(2013) Morten Lamberts et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary

(2013) G. Y. H. Lip   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Antiplatelet therapy and anticoagulants

(2013) Axel Schlitt et al.   LANCET

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

(2013) Willem JM Dewilde et al.   LANCET

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

(2013) Roxana Mehran et al.   LANCET

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology

(2013) M. J. Armstrong et al.   NEUROLOGY

Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation

(2013) David H. Birnie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

(2013) John W. Eikelboom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anticoagulation in patients with atrial fibrillation undergoing coronary stent implantation

(2013) Anne Bernard et al.   THROMBOSIS AND HAEMOSTASIS

Differences between ACC/AHA and ESC Guidelines on antiplatelet therapy in patients with acute coronary syndromes

(2013) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

(2013) Pilar Gallego et al.   THROMBOSIS AND HAEMOSTASIS

General mechanisms of coagulation and targets of anticoagulants (Section I)

(2013) Steen Husted et al.   THROMBOSIS AND HAEMOSTASIS

Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy

(2013) Kurt Huber et al.   THROMBOSIS AND HAEMOSTASIS

The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation

(2013) Laurent Azoulay et al.   THROMBOSIS AND HAEMOSTASIS

Vitamin K antagonists in heart disease: Current status and perspectives (Section III)

(2013) Raffaele Caterina et al.   THROMBOSIS AND HAEMOSTASIS

Guidelines on valvular heart disease in clinical practice

(2013) Alec Vahanian et al.   EuroIntervention

Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents

(2013) Thomas Pilgrim et al.   EuroIntervention

The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients

(2013) Carlo Di Mario et al.   EuroIntervention

Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting

(2012) L. Caballero et al.   AGE AND AGEING

Comparison of Frequency of Major Adverse Events in Patients With Atrial Fibrillation Receiving Bare-Metal Versus Drug-Eluting Stents in Their Coronary Arteries

(2012) Laurent Fauchier et al.   AMERICAN JOURNAL OF CARDIOLOGY

Antithrombotic Management and 1-Year Outcome of Patients on Oral Anticoagulation Undergoing Coronary Stent Implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry)

(2012) Andrea Rubboli et al.   AMERICAN JOURNAL OF CARDIOLOGY

Scores to Predict Major Bleeding Risk During Oral Anticoagulation Therapy: A Prospective Validation Study

(2012) Jacques Donzé et al.   AMERICAN JOURNAL OF MEDICINE

Atrial Fibrillation and Acute Myocardial Infarction: Antithrombotic Therapy and Outcomes

(2012) Renato D. Lopes et al.   AMERICAN JOURNAL OF MEDICINE

Dabigatran Association With Higher Risk of Acute Coronary Events

(2012) Ken Uchino   ARCHIVES OF INTERNAL MEDICINE

Transcatheter Aortic Valve Implantation: A Canadian Cardiovascular Society Position Statement

(2012) John Webb et al.   CANADIAN JOURNAL OF CARDIOLOGY

Antithrombotic Therapy After Coronary Stenting in Patients With Nonvalvular Atrial Fibrillation

(2012) Kay W. Ho et al.   CANADIAN JOURNAL OF CARDIOLOGY

Antithrombotic and Thrombolytic Therapy for Valvular Disease

(2012) Richard P. Whitlock et al.   CHEST

Perioperative Management of Antithrombotic Therapy

(2012) James D. Douketis et al.   CHEST

Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation

(2012) Francesco Dentali et al.   CIRCULATION

Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention

(2012) Morten Lamberts et al.   CIRCULATION

Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial

(2012) Stefan H. Hohnloser et al.   CIRCULATION

Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin

(2012) Jeff S. Healey et al.   CIRCULATION

Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

(2012) Antonio L. Dans et al.   CIRCULATION

Heparin Bridging vs. Uninterrupted Oral Anticoagulation in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting

(2012) Heli Lahtela et al.   CIRCULATION JOURNAL

Bivalirudin Versus Heparin Plus a Glycoprotein IIb/IIIa Inhibitor in Patients With Non–ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment

(2012) Gjin Ndrepepa et al.   Circulation-Cardiovascular Interventions

Should We Recommend Oral Anticoagulation Therapy in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting With a High HAS-BLED Bleeding Risk Score?

(2012) Juan M. Ruiz-Nodar et al.   Circulation-Cardiovascular Interventions

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Guidelines on the management of valvular heart disease (version 2012)

(2012) et al.   EUROPEAN HEART JOURNAL

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2012) et al.   EUROPEAN HEART JOURNAL

New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes

(2012) Raffaele De Caterina et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve Replacement

(2012) David R. Holmes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Clinical and prognostic implications of existing and new-onset atrial fibrillation in patients undergoing transcatheter aortic valve implantation

(2012) Michael Mok et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients

(2012) Martine Gilard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice

(2012) Gregory Y. H. Lip et al.   THROMBOSIS AND HAEMOSTASIS

Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor

(2012) A. G. G. Turpie et al.   THROMBOSIS AND HAEMOSTASIS

Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score

(2012) J. Gustav Smith et al.   EuroIntervention

Coronary and mortality risk of novel oral antithrombotic agents: a meta-analysis of large randomised trials

(2012) Koon-Hou Mak   BMJ Open

Antithrombotic or Anti-Platelet Agents in Patients Undergoing Permanent Pacemaker Implantation

(2012) Chang Kun Lee et al.   Korean Circulation Journal

Dual Antiplatelet Therapy Versus Aspirin Alone in Patients Undergoing Transcatheter Aortic Valve Implantation

(2011) Gian Paolo Ussia et al.   AMERICAN JOURNAL OF CARDIOLOGY

Impact of Periprocedural Atrial Fibrillation on Short-Term Clinical Outcomes Following Percutaneous Coronary Intervention

(2011) William Chan et al.   AMERICAN JOURNAL OF CARDIOLOGY

Coronary Stent Implantation in Patients Committed to Long-term Oral Anticoagulation Therapy

(2011) Andrea Rubboli et al.   CHEST

“Triple Therapy” Rather Than “Triple Threat”

(2011) Hong-Jin Zhao et al.   CHEST

Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment

(2011) A. Hakalahti et al.   EUROPACE

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

(2011) et al.   EUROPEAN HEART JOURNAL

Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial

(2011) J. Oldgren et al.   EUROPEAN HEART JOURNAL

Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices

(2011) Oscar Cano et al.   HEART RHYTHM

SAT-TAVI (Single Antiplatelet Therapy for TAVI) study: A Randomized Study Comparing double to single antiplatelet therapy for Transcatheter Aortic Valve Implantation

(2011)   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Predictors of major bleeding in peri-procedural anticoagulation management

(2011) A. J. TAFUR et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

(2011) John H. Alexander et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients

(2011) Craig R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

(2011) Jessica L. Mega et al.   NEW ENGLAND JOURNAL OF MEDICINE

No Increased Bleeding Events with Continuation of Oral Anticoagulation Therapy for Patients Undergoing Cardiac Device Procedure

(2011) HUNG-KEI LI et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Incidence and Severity of Coronary Artery Disease in Patients with Atrial Fibrillation Undergoing First-Time Coronary Angiography

(2011) Stefan Kralev et al.   PLoS One

Mild kidney disease as a risk factor for major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stenting

(2011) S. Manzano-Fernandez et al.   THROMBOSIS AND HAEMOSTASIS

Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe

(2011) K. Airaksinen et al.   THROMBOSIS AND HAEMOSTASIS

Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients

(2011) Arlene Gallagher et al.   THROMBOSIS AND HAEMOSTASIS

Chronic oral anticoagulant therapy in carotid artery stenting: The un-necessity of perioperative bridging heparin therapy

(2011) Rodolfo Pini et al.   THROMBOSIS RESEARCH

Variations in Perioperative Warfarin Management: Outcomes and Practice Patterns at Nine Hospitals

(2010) Amir K. Jaffer et al.   AMERICAN JOURNAL OF MEDICINE

Does Warfarin for Stroke Thromboprophylaxis Protect Against MI in Atrial Fibrillation Patients?

(2010) Gregory Y.H. Lip et al.   AMERICAN JOURNAL OF MEDICINE

Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation

(2010) Morten L. Hansen et al.   ARCHIVES OF INTERNAL MEDICINE

Periprocedural Anticoagulation Management of Patients With Venous Thromboembolism

(2010) Robert D. McBane et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Periprocedural Stroke and Management of Major Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation

(2010) Luigi Di Biase et al.   CIRCULATION

Comparison of Different Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation

(2010) Fei Gao et al.   CIRCULATION JOURNAL

Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting

(2010) C. Tamburino et al.   EUROPEAN HEART JOURNAL

Adverse events associated with anticoagulation therapy in the periendoscopic period

(2010) Lauren B. Gerson et al.   GASTROINTESTINAL ENDOSCOPY

Peri-procedural Anticoagulation and the Incidence of Haematoma Formation after Permanent Pacemaker Implantation in the Elderly

(2010) Vincent Chow et al.   Heart Lung and Circulation

Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation

(2010) Imdad Ahmed et al.   HEART RHYTHM

Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: A randomized clinical trial

(2010) Alan Cheng et al.   HEART RHYTHM

Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis after treatment with drug-eluting coronary stents

(2010) Yoshie Uchida et al.   Journal of Cardiology

Dual Antiplatelet Therapy and Heparin “Bridging” Significantly Increase the Risk of Bleeding Complications After Pacemaker or Implantable Cardioverter-Defibrillator Device Implantation

(2010) Christine Tompkins et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Low molecular weight heparin bridging for atrial fibrillation: is VTE thromboprophylaxis the major benefit?

(2010) Henny H. Billett et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Newly Identified Events in the RE-LY Trial

(2010) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery

(2010) Martin B. Leon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiac Resynchronization Therapy Device Implantation in Patients with Therapeutic International Normalized Ratios

(2010) HAMID GHANBARI et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Antiplatelet Therapy in Patients With Anticoagulants Undergoing Percutaneous Coronary Stenting (from STENTIng and oral antiCOagulants [STENTICO])

(2009) Martine Gilard et al.   AMERICAN JOURNAL OF CARDIOLOGY

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome

(2009)   CIRCULATION

Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study

(2009) A Sambola et al.   HEART

Periprocedural Management and In-Hospital Outcome of Patients with Indication for Oral Anticoagulation Undergoing Coronary Artery Stenting

(2009) ANDREA RUBBOLI et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?

(2009) A. STEIB et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial

(2009) JL Mega et al.   LANCET

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

(2009) G. Y. H. Lip et al.   THROMBOSIS AND HAEMOSTASIS

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

(2008) et al.   CIRCULATION

Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention

(2008) Adnan Kastrati et al.   NEW ENGLAND JOURNAL OF MEDICINE